Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Lengyel

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Orvosi Hetilap|October 20, 1996
[Therapeutic principles after liver transplantation]G Lengyel
The Journal of International Medical Research|January 8, 2004
A new approach to drug therapy in non-alcoholic steatohepatitis (NASH)J Fehér, G Lengyel
Orvosi Hetilap|December 25, 1994
[Thymostimulin in clinical practice]G Lengyel, J Fehér
Orvosi Hetilap|January 5, 1997
[Epidemiology and clinical significance of the newly discovered GB,G hepatitis viruses]J Fehér, G Lengyel
Orvosi Hetilap|October 16, 1994
[Famotidine in the treatment of gastroduodenal ulcer]G Lengyel, J Fehér
Orvosi Hetilap|January 1, 1995
[Interferon therapy in chronic active viral hepatitis]G Lengyel, J Fehér
Orvosi Hetilap|June 1, 1997
[Possibilities and perspectives of the prevention of viral hepatitis]J Fehér, G Lengyel
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Endoscopy of the bile ducts and pancreas in children]Z Tulassay, J Papp, G Lengyel
Acta Physiologica Hungarica|January 1, 1992
Role of free-radical reactions in liver diseasesJ Fehér, A Vereckei, G Lengyel
Orvosi Hetilap|June 23, 1999
[Experience with combined interferon alpha-2b and ribavirin in the therapy of chronic hepatitis C. Experience with one-year therapy of 100 patients. Multicenter study]J Fehér, G Lengyel, T Bálint
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Orvosi Hetilap|October 20, 1996
[Therapeutic principles after liver transplantation]G Lengyel
The Journal of International Medical Research|January 8, 2004
A new approach to drug therapy in non-alcoholic steatohepatitis (NASH)J Fehér, G Lengyel
Orvosi Hetilap|December 25, 1994
[Thymostimulin in clinical practice]G Lengyel, J Fehér
Orvosi Hetilap|January 5, 1997
[Epidemiology and clinical significance of the newly discovered GB,G hepatitis viruses]J Fehér, G Lengyel
Orvosi Hetilap|October 16, 1994
[Famotidine in the treatment of gastroduodenal ulcer]G Lengyel, J Fehér
Orvosi Hetilap|January 1, 1995
[Interferon therapy in chronic active viral hepatitis]G Lengyel, J Fehér
Orvosi Hetilap|June 1, 1997
[Possibilities and perspectives of the prevention of viral hepatitis]J Fehér, G Lengyel
Deutsche Zeitschrift Fur Verdauungs- Und Stoffwechselkrankheiten|January 1, 1985
[Endoscopy of the bile ducts and pancreas in children]Z Tulassay, J Papp, G Lengyel
Acta Physiologica Hungarica|January 1, 1992
Role of free-radical reactions in liver diseasesJ Fehér, A Vereckei, G Lengyel
Orvosi Hetilap|June 23, 1999
[Experience with combined interferon alpha-2b and ribavirin in the therapy of chronic hepatitis C. Experience with one-year therapy of 100 patients. Multicenter study]J Fehér, G Lengyel, T Bálint
Pageof 5